P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES

• D. Galusic,
• S. Basic - Kinda,
• A. Pijuk,
• V. Milunovic,
• B. Dreta,
• N. Franjic,
• B. Coha,
• J. Sincic – Petricevic,
• P. Gacina,
• V. Pejsa,
• M. Lucijanic,
• I. Aurer

Affiliations

D. Galusic

1 Division of Hematology, Department of Internal Medicine, University Hospital of Split

S. Basic - Kinda

3 Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb

A. Pijuk

1 Division of Hematology, Department of Internal Medicine, University Hospital of Split

V. Milunovic

4 Division of Hematology, Department of Internal Medicine, University Hospital Merkur, Zagreb

B. Dreta

3 Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb

N. Franjic

5 Division of Hematology, Department of Internal Medicine, University Hospital Centre Rijeka, Rijeka

B. Coha

6 Department of Internal Medicine, Dr. “Josip Bencevic” General Hospital, Slavonski Brod

J. Sincic – Petricevic

7 Division of Hematology, Department of Internal Medicine, University Hospital Centre Osijek, Osijek

P. Gacina

8 Division of Hematology, Department of Internal Medicine, Sestre Milosrdnice University Hospital Center

V. Pejsa

9 Division of Hematology, Department of Internal Medicine, University Hospital Dubrava

M. Lucijanic

9 Division of Hematology, Department of Internal Medicine, University Hospital Dubrava

I. Aurer

3 Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb